CSPI Newsroom |
FDA, FTC Warn Companies Marketing Supplements as Opioid Addiction Withdrawal Aids
CSPI Newsroom The U.S. Food and Drug Administration and the Federal Trade Commission today warned marketers and distributors of 12 dietary supplements marketed as opioid withdrawal aids that they can no longer market these products with drug treatment claims—a big ... FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims |
January 24, 2018 at 03:32PM | marketing - Google News
FDA, FTC Warn Companies Marketing Supplements as Opioid Addiction Withdrawal Aids - CSPI Newsroom
marketing - Google News
Nenhum comentário:
Postar um comentário